Mersana Therapeutics, Inc. (MRSN)
Delisted
6 Jan 2026
NASDAQ (NGS) NASDAQ (NGS) Primary $
29. 08
0
0%
$
145.36M Market Cap
- P/E Ratio
- Div Yield
624,025 Volume
-1.53 Eps
$ 29.08
Previous Close Investors:
Day Range
28.78 29.08
Year Range
5.21 30.39
Want to track MRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mersana Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| GLF Groupe La Francaise Groupe La Francaise | 61,488 | $1.78M | $1.78M | - | - |
